● LIVE GMP Last Updated: January 17, 2026 | Research Desk: Positional Calls
This institutional-grade analysis covers KRM Ayurveda IPO GMP today , price band, Q3 results, technical levels, risks, and a data-backed Share Price Target 2026 (₹185–₹215) .
🔹 Quick Snapshot
Metric
Data
IPO Price Band
₹128 – ₹135
GMP Today
₹15 (≈ 11.1%)
Expected Listing
₹150 – ₹155
Share Price Target 2026
₹185 – ₹215
Issue Size
₹77.49 Cr (Fresh Issue)
Listing
NSE SME
Trend Bias
Bullish (Long Term)
Risk Rating
Medium–High (SME)
1) Fundamental Indicators: The Growth Engine
Metric
FY24
FY25
Revenue
₹67.16 Cr
₹76.55 Cr
PAT
₹3.41 Cr
₹12.10 Cr (+254.84%)
Debt/Equity
1.31x (Pre-IPO)
Debt Reduction
₹12.50 Cr from IPO proceeds
Q3 Results Snapshot (FY25)
Metric
Q3 FY25
YoY Change
Revenue
₹64 Cr
+24%
EBITDA Margin
16.8%
+120 bps
PAT
₹6.4 Cr
+28%
Order Book
₹210 Cr
—
2) Technical & Valuation Roadmap—2026 Targets
Level
Price
Interpretation
Expected Listing
₹150–₹155
Based on GMP
Accumulation Zone
₹138–₹142
Post-listing support
Target 1 (2026)
₹185
Momentum breakout
Target 2 (2026)
₹215
Base case target
Stop Loss
₹125
Risk control
3) Peer Comparison
Company
P/E
ROE
Growth
Valuation
KRM Ayurveda
17.3x
67.9%
High
Undervalued
Jeena Sikho Lifecare
~76x
Lower
Medium
Overvalued
4) Risk Management—Defensive Playbook
Geographic concentration (68% revenue from Delhi/Haryana)
Negative operating cash flow in FY25
SME liquidity risk
Risk Controls:
Stop Loss: ₹125
Entry: Staggered post-listing
Position Size: Max 5–8%
KRM Ayurveda IPO GMP Today—Live View
Date
GMP (₹)
Trend
Expected Listing
17 Jan 2026
₹15
🟢 Bullish
₹150–₹155
🔗 Internal Links
Final Verdict
Bullish for 2026 —Strong growth + undervaluation + AYUSH tailwinds support the ₹185–₹215 target.
Compliance & Disclosure: Educational content only. Not SEBI-registered advice.
About The Author
“Positional Calls Team provides data-driven positional stock calls, IPO analysis, and technical market insights with a focus on risk management and disciplined trading.”